Filing Digest
Sep 14
NPK International Inc. announced the appointment of James Barton as Executive Vice President, Commercial Growth & Operations, effective September 22, 2026. Mr. Barton succeeds Lori…
Filing Digest
Sep 14
Cullinan Therapeutics, Inc. filed a Current Report on Form 8-K on September 13, 2026, announcing the results of the Phase 3 REZILIENT3 clinical trial. The trial evaluated the combi…
Filing Digest
Sep 14
Soluna Holdings, Inc. announced on September 14, 2026, that the Electric Reliability Council of Texas (ERCOT) has conditionally classified its 100 MW Project Dorothy campus as Base…
Filing Digest
Sep 14
PBF Energy Inc. and its subsidiary PBF Holding Company LLC announced two significant corporate developments on September 14, 2026. The company disclosed the acquisition of hydrogen…
Filing Digest
Sep 14
On September 14, 2026, Texas Capital Bancshares, Inc. filed a Form 8-K announcing its intention to voluntarily withdraw its common stock and Series B preferred stock from the Nasda…
Filing Digest
Sep 14
KeyCorp filed a Current Report on Form 8-K on September 14, 2026, to disclose updated financial guidance and a presentation for the Barclays Global Financial Services Conference he…
Filing Digest
Sep 14
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced on September 14, 2026, that research conducted by The Ohio State University College of Veterinary Medicine has demonstrated th…
Filing Digest
Sep 14
Scholar Rock Holding Corporation announced on September 11, 2026, that the U.S. Food and Drug Administration (FDA) has approved ISEMBYLD (apitegromab-mstn) for the treatment of spi…
Filing Digest
Sep 14
Piedmont Realty Trust, Inc. (NYSE: PDM) announced a proposed private offering of $200,000,000 aggregate principal amount of exchangeable senior notes due 2031. The notes are to be …
Filing Digest
Sep 14
Thryv Holdings, Inc. (NASDAQ: THRY) has entered into a definitive agreement to sell its print directories business to Carolwood L.P. for a total cash consideration of $142 million,…
Filing Digest
Sep 14
Definium Therapeutics, Inc. announced on September 14, 2026, that its Phase 3 Panorama study of DT120 Orally Disintegrating Tablet (ODT) for generalized anxiety disorder (GAD) met …
Filing Digest
Sep 14
Essential Properties Realty Trust, Inc. filed a Form 8-K on September 14, 2026, disclosing the release of an Investor Presentation and Supplemental Information for September 2026. …
Filing Digest
Sep 14
RF Industries, Ltd. (NASDAQ: RFIL) announced financial results for the third quarter of fiscal year 2026, which ended on July 31, 2026. The company reported record net sales of $23…
Filing Digest
Sep 14
NETSTREIT Corp. filed a Form 8-K on September 14, 2026, announcing the release of an investor presentation. The company stated that the presentation is intended for use during meet…
Filing Digest
Sep 14
Boeing Co. has announced that all flight testing for the 737 MAX 10 has been completed. The company stated that it aims to have the aircraft certified very soon.
Filing Digest
Sep 14
Perspective Therapeutics Inc. (CATX) has announced a clinical trial collaboration with Merck & Co. (MRK) to test the company's investigational drug PSV359 in combination with Merck…
Filing Digest
Sep 14
Lipocine Inc. has announced the initiation of the BLOOM Phase 3 clinical study for its investigational drug candidate LPCN 1154, also referred to as oral brexanolone, to treat post…
Filing Digest
Sep 14
Perspective Therapeutics, Inc. announced on September 14, 2026, a clinical collaboration and supply agreement with Merck (NYSE: MRK). Under the terms of the agreement, Perspective …
Filing Digest
Sep 14
Addentax Group Corp. entered into private placement agreements on September 9, 2026, with Mr. Chan Chun Hong. Under the terms of the agreements, the company agreed to issue and sel…
Filing Digest
Sep 14
Toyota Motor Credit Corporation (TMCC) announced on September 11, 2026, the renewal of its Euro Medium Term Note Programme (EMTN Program). The program, which allows for the issuanc…